jeudi 12 mai 2016

Onco Actu du 12 mai 2016

3.1.1 Tabac - e-cigs

Smoke out [Nature News & Comment]

3.2 Prévention - Obésité

BMI categories may need adjusting, argue researchers [NHS Choices]

4. Dépistage, diagnostic et pronostic

NHS England to stream £15m into better cancer diagnosis [Pharma Times]

5. Traitements

Microwave Ablation for Treating Liver Metastases [ESMO]

5.2.1 Pharma - Partenariats

A Professor’s View On Drug Company Collaborations [In the Pipeline]

5.2.3 Pharma - économie

After rivals’ IPOs, will CRISPR Therapeutics go public or stay buttoned-down? [STAT]

5.3 Traitements - FDA, EMA,...

Industry Calls for More Guidance From FDA on New Clinical Trials Technology [RAPS]

Supporting innovative SMEs as major drivers of new pharmaceutical developments [EMA]

Can regulators influence the affordability of medicines? [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

Bristol-Myers Squibb and AbbVie Announce European Commission Approval of Empliciti™ (elotuzumab) for the Treatment of Multiple Myeloma in Adult Patients Who Have Received at Least One Prior Therapy [BMS]

European Commission Approves the First and Only Immuno-Oncology Combination, Bristol-Myers Squibb’s Opdivo® (nivolumab) + Yervoy® (ipilimumab) Regimen, for Treatment of Advanced Melanoma [BMS]

AstraZeneca drug wins orphan status in thyroid cancer [Reuters]

5.4 Traitements - Economie

NICE turns down Opdivo for lung cancer [Pharma Times]

Would A Wider Variety Of Vial Sizes Reduce The Cost Of Chemotherapy? Not Likely [Health Affairs]

5.9 AACR

Advances in Pancreatic Cancer Research: Q&A With Christine Iacobuzio-Donahue, MD, PhD [CANCER RESEARCH Catalyst]

6. Lutte contre les cancers

The Improvisational Oncologist [NY Times]

6.10 Politiques

Ex-FDA head and Sanofi call for harmonized drug regulation [Reuters]

6.6 Publications

NIH appoints Patricia Flatley Brennan, R.N., Ph.D., to lead the National Library of Medicine [NIH]

The pressure to publish pushes down quality [Nature News & Comment]